JP2006522790A - エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 - Google Patents

エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 Download PDF

Info

Publication number
JP2006522790A
JP2006522790A JP2006506461A JP2006506461A JP2006522790A JP 2006522790 A JP2006522790 A JP 2006522790A JP 2006506461 A JP2006506461 A JP 2006506461A JP 2006506461 A JP2006506461 A JP 2006506461A JP 2006522790 A JP2006522790 A JP 2006522790A
Authority
JP
Japan
Prior art keywords
eletriptan
sodium bicarbonate
migraine
pharmaceutically acceptable
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006506461A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン ハンフリー，マイケル
Original Assignee
ファイザー・インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0308469A external-priority patent/GB0308469D0/en
Priority claimed from GB0312479A external-priority patent/GB0312479D0/en
Application filed by ファイザー・インク filed Critical ファイザー・インク
Publication of JP2006522790A publication Critical patent/JP2006522790A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006506461A 2003-04-11 2004-03-31 エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 Pending JP2006522790A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0308469A GB0308469D0 (en) 2003-04-11 2003-04-11 Pharmaceutical combination
GB0312479A GB0312479D0 (en) 2003-05-30 2003-05-30 Pharmaceutical combination
PCT/IB2004/001115 WO2004089365A1 (fr) 2003-04-11 2004-03-31 Combinaison pharmaceutique a base d'eletriptan et de bicarbonate de sodium

Publications (1)

Publication Number Publication Date
JP2006522790A true JP2006522790A (ja) 2006-10-05

Family

ID=33161221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506461A Pending JP2006522790A (ja) 2003-04-11 2004-03-31 エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物

Country Status (12)

Country Link
EP (1) EP1615635A1 (fr)
JP (1) JP2006522790A (fr)
AR (1) AR044009A1 (fr)
BR (1) BRPI0409127A (fr)
CA (1) CA2521902A1 (fr)
MX (1) MXPA05010070A (fr)
NL (1) NL1025908C2 (fr)
PA (1) PA8599901A1 (fr)
PE (1) PE20050086A1 (fr)
TW (1) TW200423929A (fr)
UY (1) UY28260A1 (fr)
WO (1) WO2004089365A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017137306A (ja) * 2016-02-02 2017-08-10 第一三共ヘルスケア株式会社 トリプタンとアスコルビン酸を含有する医薬組成物
JP2021529759A (ja) * 2018-07-03 2021-11-04 アクスサム セラピューティクス インコーポレイテッド メロキシカムを含有する医薬組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
IT1393700B1 (it) 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6341420A (ja) * 1986-08-01 1988-02-22 ザンボン　グループ　エス　ピー　エー 鎮痛作用を有する医薬組成物
JPH06321777A (ja) * 1993-03-26 1994-11-22 Zambon Group Spa 鎮痛作用を有する薬剤組成物
JP2000344667A (ja) * 1999-05-14 2000-12-12 Pfizer Prod Inc 片頭痛処置のための併用療法
JP2001513801A (ja) * 1997-03-05 2001-09-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パラセタモールを含む嚥下錠剤
WO2002009675A1 (fr) * 2000-08-02 2002-02-07 Pfizer Limited Composition particulaire d'eletriptan presentant un modele sigmoide de liberation commandee
JP2004529893A (ja) * 2001-03-01 2004-09-30 ファイザー・インク 改善されたバイオアベイラビリティーを有する組成物
JP2005515991A (ja) * 2001-12-05 2005-06-02 グラクソ　グループ　リミテッド ５ｈｔ１レセプターアゴニストを含む医薬組成物
JP2006523620A (ja) * 2003-02-19 2006-10-19 バイオヴェイル ラボラトリーズ インコーポレイテッド 急速吸収選択的５−ｈｔ作用剤製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
GB9816556D0 (en) 1998-07-30 1998-09-30 Pfizer Ltd Therapy
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6341420A (ja) * 1986-08-01 1988-02-22 ザンボン　グループ　エス　ピー　エー 鎮痛作用を有する医薬組成物
JPH06321777A (ja) * 1993-03-26 1994-11-22 Zambon Group Spa 鎮痛作用を有する薬剤組成物
JP2001513801A (ja) * 1997-03-05 2001-09-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パラセタモールを含む嚥下錠剤
JP2000344667A (ja) * 1999-05-14 2000-12-12 Pfizer Prod Inc 片頭痛処置のための併用療法
WO2002009675A1 (fr) * 2000-08-02 2002-02-07 Pfizer Limited Composition particulaire d'eletriptan presentant un modele sigmoide de liberation commandee
JP2004529893A (ja) * 2001-03-01 2004-09-30 ファイザー・インク 改善されたバイオアベイラビリティーを有する組成物
JP2005515991A (ja) * 2001-12-05 2005-06-02 グラクソ　グループ　リミテッド ５ｈｔ１レセプターアゴニストを含む医薬組成物
JP2006523620A (ja) * 2003-02-19 2006-10-19 バイオヴェイル ラボラトリーズ インコーポレイテッド 急速吸収選択的５−ｈｔ作用剤製剤

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017137306A (ja) * 2016-02-02 2017-08-10 第一三共ヘルスケア株式会社 トリプタンとアスコルビン酸を含有する医薬組成物
JP2021529759A (ja) * 2018-07-03 2021-11-04 アクスサム セラピューティクス インコーポレイテッド メロキシカムを含有する医薬組成物
JP7237375B2 (ja) 2018-07-03 2023-03-13 アクスサム セラピューティクス インコーポレイテッド メロキシカムを含有する医薬組成物
JP7485807B2 (ja) 2018-07-03 2024-05-16 アクスサム セラピューティクス インコーポレイテッド メロキシカムを含有する医薬組成物

Also Published As

Publication number Publication date
EP1615635A1 (fr) 2006-01-18
MXPA05010070A (es) 2005-11-23
WO2004089365A1 (fr) 2004-10-21
PA8599901A1 (es) 2005-02-04
UY28260A1 (es) 2004-11-30
AR044009A1 (es) 2005-08-24
NL1025908A1 (nl) 2004-10-13
CA2521902A1 (fr) 2004-10-21
TW200423929A (en) 2004-11-16
BRPI0409127A (pt) 2006-03-28
NL1025908C2 (nl) 2005-11-22
PE20050086A1 (es) 2005-03-01

Similar Documents

Publication Publication Date Title
CA2577740C (fr) Procede permettant d'ameliorer l'absorption des formulations administrees par voie transmuqueuse
JP2006527195A (ja) トリプタンおよびｎｓａｉｄを含む組成物
JP2003522145A (ja) セントラルカンナビノイドレセプター拮抗剤のタバコ消費を止める助けに有用である医薬品への使用
JP2011500505A (ja) オルメサルタンメドキソミル及びアムロジピンの固形製剤
JP2016053094A (ja) 口腔内分散性製剤
KR20040044990A (ko) 구강내 붕해성 발데콕시브 조성물
JP2004502734A (ja) 一酸化窒素シンターゼ活性の増強方法
JP3699969B2 (ja) ５ｈｔ１レセプターアゴニストを含む医薬組成物
KR102239291B1 (ko) 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
BG65309B1 (bg) Използване на елетриптан за профилактика на мигренозен рецидив
US20040204475A1 (en) Pharmaceutical combination
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
JP2002255814A (ja) アスピリンを含有する医薬組成物
JP2006522790A (ja) エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
SG190326A1 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
EA007952B1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии
TWI574690B (zh) 立即釋放４－甲基－３［［４－（３－吡啶基）－２－嘧啶基］胺基］－ｎ－［５－（４－甲基－１ｈ－咪唑－１－基）－３－（三氟甲基）苯基］苯甲醯胺調配物
US20020099059A1 (en) Combination therapy for the treatment of migraine
JP2009535336A (ja) 片頭痛治療用の固定組合せ剤形
JP6529822B2 (ja) トリプタン系化合物を含有する口腔内崩壊錠
US20220287973A1 (en) Orodispersible powder composition comprising a triptan
EP2246046A1 (fr) Comprimé d'olanzapine à désintégration orale
TR2021020750A2 (tr) Oral yolla dağilan di̇klofenak ve eletri̇ptan kombi̇nasyonu
KR20210074428A (ko) 암로디핀, 로자탄 및 클로르탈리돈을 포함하는 약제학적 복합제제
SATYANARAYANA et al. INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070330

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20071011

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071011

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101025

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101101

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101220

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101228

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110404